<i>SGK1</i>mutation status can further stratify patients with germinal center B‐cell‐like diffuse large B‐cell lymphoma into different prognostic subgroups-Reference-Cited by-同舟云学术

SGK1mutation status can further stratify patients with germinal center B‐cell‐like diffuse large B‐cell lymphoma into different prognostic subgroups

Published:2022-02 Issue:5 Volume:11 Page:1281-1291
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Guo Baoping¹,Huang Yujie¹,Duan Ying¹,Liao Chengcheng¹^ORCID,Cen Hong¹^ORCID

Affiliation:

1. Department of Chemotherapy Guangxi Medical University Affiliated Tumor Hospital Nanning China

Funder

Natural Science Foundation of Guangxi Province

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4550

Reference31 articles.

1. Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma

2. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

3. Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report

4. MYD88 mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavorable prognosis

5. MYD88 L265P mutation detected by digital PCR as a prognostic factor in patients with diffuse large B-cell lymphoma in rituximab era

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of RNA Splicing Mutations in Diffuse Large B Cell Lymphoma;International Journal of General Medicine;2023-06

2. Targeted sequencing reveals the relationship between mutations and patients’ clinical indicators, blood cell counts and early progression in diffuse large-B cell lymphoma;Leukemia & Lymphoma;2022-10-10